Skip to main content
. 2017 Aug 11;7(8):e016269. doi: 10.1136/bmjopen-2017-016269

Table 1.

Schedule of enrolment, interventions and assessments

Study period
Enrolment Allocation Treatment Follow-up
Timepoint -wk1 wk0 wk1 wk3 wk4 wk5 wk9
Enrolment
 Eligibility screen X
 Informed consent X
 Allocation X
Interventions
 EA graphic file with name bmjopen-2017-016269ieq01.jpg
 Sham EA graphic file with name bmjopen-2017-016269ieq01.jpg
 Usual care graphic file with name bmjopen-2017-016269ieq01.jpg
Assessments
 ISI X X X X X
 PSQI X X X X
 Sleep diary graphic file with name bmjopen-2017-016269ieq02.jpg graphic file with name bmjopen-2017-016269ieq03.jpg
 Actigraphy graphic file with name bmjopen-2017-016269ieq02.jpg graphic file with name bmjopen-2017-016269ieq04.jpg graphic file with name bmjopen-2017-016269ieq04.jpg
 FACT-F X X
 MoCA X X
 BDSS X
 Salivary hormone test X X
 Blinding/credibility test* X X
 Adverse event X X X X X
 Laboratory test† X X

*Only EA and sham EA groups will undergo blinding and credibility tests.

†The laboratory test includes complete blood count and differential count, absolute neutrophil count, aspartate aminotransferase, alanine aminotransferase, total bilirubin, blood urea nitrogen, creatinine, albumin, erythrocyte sedimentation rate, thyroid-stimulating hormone, free thyroxine and human chorionic gonadotropin urine test (only for women in their childbearing years at the screening visit).

BDSS, Blood Deficiency Scoring System; EA, electroacupuncture; FACT-F, Functional Assessment of Cancer Therapy-Fatigue; ISI, Insomnia Severity Inventory; MoCA, The Montreal Cognitive Assessment; PSQI, Pittsburgh Sleep Quality Index.